Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.
about
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate.Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.
P2860
Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Equivalent and sufficient effe ...... patients with prostate cancer.
@en
Equivalent and sufficient effe ...... patients with prostate cancer.
@nl
type
label
Equivalent and sufficient effe ...... patients with prostate cancer.
@en
Equivalent and sufficient effe ...... patients with prostate cancer.
@nl
prefLabel
Equivalent and sufficient effe ...... patients with prostate cancer.
@en
Equivalent and sufficient effe ...... patients with prostate cancer.
@nl
P2093
P2860
P1433
P1476
Equivalent and sufficient effe ...... patients with prostate cancer.
@en
P2093
Iwao Fukui
Junji Yonese
Satoru Kawakami
Shinya Yamamoto
Yasuhisa Fujii
Yuhei Okubo
P2860
P304
P356
10.1111/J.1464-410X.2007.07374.X
P577
2008-01-08T00:00:00Z